设为首页 加入收藏

TOP

ellaOne 30 mg tablet Ulipristal
2015-01-12 18:57:14 来源: 作者: 【 】 浏览:512次 评论:0

For doctors

 

What is it and how is it used?

ellaOne is an oral emergency contraceptive, which means that it can be used to prevent pregnancy after unprotected sex or if your contraceptive method has failed, for example:

You can use ellaOne up to 120 hours (5 days) after unprotected sex or failure of a contraceptive method.

ellaOne acts by modifying the activity of the natural hormone progesterone. ellaOne is thought to work by stopping your ovaries from releasing an egg. ellaOne is not effective in every case: of 100 women receiving ellaOne up to 5 days after unprotected sex, approximately 2 will become pregnant.

ellaOne is not suitable as a regular method of contraception.

What do you have to consider before using it?

Do not use ellaOne

Take special care with ellaOne

Emergency contraception is a backup method for preventing pregnancy and should only be used occasionally. Only limited information is available concerning the safety and efficacy of repeated use of ellaOne; therefore, you are advised not to use ellaOne more than once in the same menstrual cycle. Your doctor or healthcare provider can tell you about long-term methods of contraception that may be appropriate for you.

Tell your doctor, healthcare provider or pharmacist if you have liver disease. It is not recommended to use ellaOne in case of severe liver disease.

Tell your doctor if you have severe asthma.

After using ellaOne, if you want to have sex, you should use a reliable barrier contraceptive method such as condom. This is because ellaOne will not work if you have unprotected sex again.

If you are currently taking hormonal contraception (for example birth control pills), you can continue as usual immediately after taking ellaOne but you should use a reliable barrier contraceptive method such as condom until your next period (see “Taking other medicines”)

After taking ellaOne, most women have a normal period at the expected time, but some may have their period later or earlier than normal (see paragraph 4 “POSSIBLE SIDE EFFECTS”). If your period is more than 7 days late or is unusually light or unusually heavy or if you experience symptoms such as abdominal pain, nausea, vomiting or breast pain or if you have any doubt about being pregnant, you should perform a pregnancy test to make sure you are not pregnant.

If you do become pregnant after taking ellaOne, it is important to contact your doctor. Your doctor may want to check that the pregnancy is not ectopic (where the baby develops somewhere outside the womb). This is especially important if you develop severe abdominal pain or bleeding after taking ellaOne or if you have previously had an ectopic pregnancy, Fallopian tube surgery or long term (chronic) genital infection (pelvic inflammatory disease).

If you are worried about sexually transmitted diseases: ellaOne will not protect you against HIV infection (AIDS) or any other sexually transmitted diseases (e.g. chlamydia, genital herpes, genital warts, gonorrhoea, hepatitis B and syphilis). Only condoms can protect you from these diseases. Ask your doctor or healthcare provider for advice if you are worried about this.

Taking other medicines

Please tell your doctor, healthcare provider or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

Be sure to tell your doctor or pharmacist if you are taking any of the medicines listed below, as these medicines can make ellaOne less effective in preventing pregnancy:

ellaOne may also make regular hormonal contraceptives less effective. Therefore you should use a reliable barrier contraceptive method such as condom until your next period.

ellaOne should not be used together with emergency contraceptives containing levonorgestrel.

The activity of ellaOne may be increased if you are taking certain medicines such as medicines to treat fungal infections (for example, ketoconazole, itraconazole), or certain infections (for example, telithromycin, clarithromycin) as they may increase the amount of ellaOne in your body.

Pregnancy and breast-feeding

ellaOne is not to be taken if you are already pregnant. Using ellaOne while pregnant might affect your pregnancy. In case of doubt about a pregnancy, you should perform a pregnancy test (see ”Take special care with ellaOne”).

If you do become pregnant after taking this medicine, it is important that you contact your doctor, healthcare provider or pharmacist.

If you are breast-feeding

Breast-feeding is not recommended in the 36 hours following ellaOne intake: if you take ellaOne while breast-feeding, you should breast-feed your baby immediately before taking the ellaOne tablet, then pump and discard your milk for 36 hours after ellaOne intake. Breast-feeding can be resumed after 36 hours.

Driving and using machines

After ellaOne intake, some women experience dizziness, drowsiness, blurred vision and/or disturbance in attention (see paragraph 4 “POSSIBLE SIDE EFFECTS”): do not drive or use machines if you experience these symptoms.

Important information about some of the ingredients of ellaOne

ellaOne contains lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

How is it used?

Always use ellaOne exactly as your doctor, healthcare provider or pharmacist has told you. You should check with your doctor, healthcare provider or pharmacist if you are not sure.

If you use more ellaOne than you should

There have been no reports of serious harmful effects from taking several doses of this medicine at once. You should nonetheless ask your doctor, healthcare provider or pharmacist for advice.

If you have any further questions on the use of this product, ask your doctor, healthcare provider or pharmacist.

What are possible side effects?

Like all medicines, ellaOne can cause side effects, although not everybody gets them.

The frequency of possible side effects listed below is defined using the following convention: 20
common (affects 1 to 10 users in 100)
uncommon (affects 1 to 10 users in 1,000)
rare (affects 1 to 10 users in 10,000)

Common side effects:

Uncommon side effects:

Rare side effects:

If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, healthcare provider or pharmacist.

How should it be stored?

Keep out of the reach and sight of children.

Do not use ellaOne after the expiry date which is stated on the carton and on the blister after EXP. The expiry date refers to the last day of that month.

Keep the blister in the outer carton in order to protect from light.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

↑ back to table of contents ↑

For doctors

What is it?

EllaOne is a medicine that contains the active substance ulipristal acetate. It is available as white tablets (30 mg).

What is it used for?

EllaOne is a female emergency contraceptive to be taken within 120 hours (five days) of unprotected sex or contraceptive failure (such as a tear in a condom during sex).

The medicine can only be obtained with a prescription.

How is it used?

EllaOne is taken as one tablet by mouth as soon as possible, but no later than 120 hours, after unprotected sex or contraceptive failure. If the woman vomits within three hours of taking the medicine she should take another tablet. EllaOne can be taken at any time during the menstrual cycle.

How does it work?

For pregnancy to occur there has to be ovulation (release of eggs) followed by the fertilisation of the egg (fusion with a sperm) and implantation in the womb. The sex hormone progesterone plays a role in the timing of ovulation and in preparing the lining of womb to receive the fertilised egg.

The active substance in ellaOne, ulipristal acetate, acts as a progesterone receptor modulator. This means that it attaches to the receptors that progesterone normally attaches to, preventing the hormone from having its effect. Through its actions on the progesterone receptors, ellaOne prevents pregnancies mainly by preventing or delaying ovulation.

How has it been studied?

In one main study, ellaOne was given to 1,533 women (aged on average 24 years) who had requested emergency contraception between two and five days after unprotected sex or contraceptive failure. The main measure of effectiveness was the number of women who did not become pregnant. This number was then compared with the number of women who would have been expected to become pregnant if they had not taken a contraceptive. This number was calculated from published pregnancy rates.

An additional study compared ellaOne with levonorgestrel (another medicine used in emergency contraception). This study included women who took the medicine within two days of unprotected sex or contraceptive failure.

What benefits has it shown during the studies?

EllaOne was effective as an emergency contraceptive, reducing the number of unintended pregnancies. Of the women who completed the main study, 2.1% (26 out of 1,241) became pregnant. This is less than the 5.5% of women who would have been expected to become pregnant if they had not taken any contraceptive. EllaOne therefore prevented about three-fifths of the pregnancies.

The additional study, which included women who took the medicine within two days of unprotected sex or contraceptive failure, supported the effectiveness of ellaOne. In this study, ellaOne was as effective as levonorgestrel at preventing pregnancies.

What is the risk associated?

The most common side effects with ellaOne (seen in more than 1 patient in 10) are headache, nausea (feeling sick) and abdominal pain (stomach ache). For the full list of all side effects reported with ellaOne, see the package leaflet.

EllaOne should not be used in women who may be hypersensitive (allergic) to ulipristal acetate or any of the other ingredients. It must not be used in women who are already pregnant.

Why has it been approved?

The CHMP decided that ellaOne’s benefits are greater than its risks and recommended that it be given marketing authorisation.

Further information

The European Commission granted a marketing authorisation valid throughout the European Union for ellaOne to Laboratoire HRA Pharma on 15 May 2009. The marketing authorisation is valid for five years, after which it can be renewed.

For more information about treatment with ellaOne, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.

This summary was last updated in 06-2010.

↑ back to table of contents ↑
 

Name

 

ellaOne 30 mg tablet

 

Composition

 

Each tablet contains 30 mg ulipristal acetate.

Excipients: each tablet contains 237 mg lactose monohydrate.

For a full list of excipients, see section 6.1.

 

Pharmaceutical Form

 

Tablet
White to off-white, round curved tablet engraved with code “-ll-” on both faces

 

Are you an Healthcare Professional? Access professional drug leaflets on Diagnosia.com!

 

以下是“全球医药”详细资料
Tags: 责任编辑:admin
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇ellaOne 30 mg tablet 下一篇EllaOne (ulipristal acetate)

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位